CH421072A - Process for the preparation of 2- (3'-hydroxy-3'-methyl-5'-carboxy-pentyl) -3,5,6-trimethyl-benzoquinone - Google Patents

Process for the preparation of 2- (3'-hydroxy-3'-methyl-5'-carboxy-pentyl) -3,5,6-trimethyl-benzoquinone

Info

Publication number
CH421072A
CH421072A CH367262A CH367262A CH421072A CH 421072 A CH421072 A CH 421072A CH 367262 A CH367262 A CH 367262A CH 367262 A CH367262 A CH 367262A CH 421072 A CH421072 A CH 421072A
Authority
CH
Switzerland
Prior art keywords
trimethyl
methyl
hydroxy
pentyl
benzoquinone
Prior art date
Application number
CH367262A
Other languages
German (de)
Inventor
Green Joseph
Mchale David
Original Assignee
Vitamins Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitamins Limited filed Critical Vitamins Limited
Publication of CH421072A publication Critical patent/CH421072A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C66/00Quinone carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

  



  Verfahren zur Herstellung von   2- (3'-Hydroxy-3'-methyl-5'-carboxy-pentyl)-       3, 5, 6-trimethyl-benzochinon   
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von   2-(3'-Hydroxy-3'-methyl-5'-carS    oxy-pentyl)-3, 5, 6-trimethyl-benzochinon (I), welches als Ausgangsstoff zur Herstellung des entsprechenden Tocopheronlactons   (II)    verwendet werden kann.
EMI1.1     

EMI1.2     




   Diese Verbindungen wurden als metabolische Produkte   des Vitamins    E   (a-Tocopherol)    von Simon, Eisengart, Sundheim und   Milhorat    [vgl. J. Biol.



  Chem., (1956), 221, 807], isoliert und es wird angenommen, dass sie von Bedeutung wie die aktive metabolische Form des Vitamins sind.   Tocopheron-    lacton wurde kürzlich von Weichet, Blaha  &  Kakac [vgl.   Coll.    Czech. Chem. Commun., (1959) 24, 1989] synthetisiert.

   Das erfindungsgemässe Verfahren ist dadurch gekennzeichnet, dass 2, 3,   5-Trimethyl-hydro-    chinon mit Geraniol oder   Linalool    unter solchen Bedingungen kondensiert wird, dass die Bildung tricyclischer Produkte unterbleibt oder nur in vermin  dertem    Ausmass eintritt, und danach das erhaltene
2, 5, 7,   8-Tetramethyl-2-(4'-methylpent-3'-enyl)       chroman-6-ol    der Formel
EMI1.3     
 an der olefinischen Doppelbindung zum Chromanol der Formel 
EMI2.1     
 oxydiert und dieses zum Benzochinon der Formel I   weiteroxydiert.    Für die erste Stufe   geeignete Re-    aktionsbedingungen sind z.

   B. die Anwendung von Kondensationsmitteln, wie Fluorwasserstoff oder   Bortrifluoridlätherat,    vorzugsweise zusammen mit Kondensationsmitteln, wie Schwefelsäure, Ameisensäure, Zinnchlorür oder Zinkchlorid in einem inerten Lösungsmittel bei Temperaturen zwischen Zimmertemperatur und   120  C, insbesondere zwischen    25 und   50  C.    Das erhaltene Cromanol (III wird hierauf, am besten unter genau   eingehaltenen    Oxydationsbedingungen, zum Chromanol (IV) und anschliessend zur Hydroxysäure   (I)    oxydiert. Die letztere lässt sich nach bekannten Verfahren in das Tocopheronlacton   (II)    überführen. Als besonders geeignetes Oxydationsmittel für die genannte Oxydation hat sich Ozon erwiesen.

   Das bei der   Ozoneinwirkung    erhaltene Produkt wird unter oxydierenden Bedingungen aufgearbeitet, wie sie bekannt sind zur   Umwandlung olefini ;    scher Substanzen in Säuren. Gegebenenfalls kann die Hydroxygruppe des Chromanols   (III),    welche unter gewissen Bedingungen der Oxydation unterliegt,   vor-    her in eine   andere Gruppe wie eine Ester-oder      Athergruppe    übergeführt werden, und die auf diese Weise vor unerwünschter Oxydation geschützte Verbindung vermittels Ozon oder einem anderen oxydierenden Agens, wie z.   B.    eine Chromsäuremischung, oxydiert werden.

   Beispiele derartiger Ester sind das Acetat, das Propionat oder das   Benzoat    und'Beispiele von Athem sind der Methyl-, Äthyl-und   Benzyläther.    Nach der Oxydation lässt sich die schützende Gruppe nach bekannten Verfahren ent  ferre,    (Ester vermiittels Hydrolyse, die Benzylgruppe vermittels Hydrogenolyse usw.), wobei das Tocopheronlacton entsteht.



   In den nachfolgenden Beispielen sind die angegebenen Teile   GewichtsteNe.   



   Beispiel 1
20 Teile 2, 3,   5-Trimethylhydrochinon,    20 Teile Geraniol und   5    Teile   BF3-ätherat    werden in 200 Teilen   peroxydfreiem    Dioxan 8 Stunden lang auf   50  C erhitzt.    Das Gemenge wird hiernach mit Pe  troläther    verdünnt und das Dioxan sowie unver ändertes   HydrochinondeTivat    daraus zuerst mit Alkali und dann mit Wasser herausgewaschen. Das erhaltene Öl wird an Aluminiumoxyd chromatographiert.

   Nachdem mit Benzol   terpenähnliche    Substanzen eluiert wurden, ergibt Eluieren mit 5%Äthanol'in Benzol ein hellgelbes   01.    Es wird in einem   Kurzweg-Mole-      kulardestilEerkolben (120     C, 10 Micron) destilliert, wobei man das Chromanol (III) in Form eines Öles n D 20 = 1, 5323 erhält. 20 Teile dieses Chromanols werden acetyliert und, ohne dass d'as Acetat isoliert worden wäre, in 600 Teilen Essigsäure bei Zimmertemperatur aufgelöst, wonach durch die Lösung trockener ozonhaltiger Sauerstoff   durchgeblasen    wird.



  Nachdem die zur Oxydation einer Doppelbindung benötigte Menge Ozon absorbiert worden ist, wird die Lösung langsam zu einem Gemisch von 30% Was  serstoffperoxyd    und n Schwefelsäure zugegeben und hernach vorsichtig erwärmt. Nun wird das   Ge-    menge 2 Stunden lang am Rückfluss gekocht. Nach dem Abkühlen wird das Gemisch mit Ather extrahiert. Nach dem Verdampfen des Lösungsmittels aus dem Atherextrakt erhält man das Acetat des   Chro-      manols    (IV) vom Smp.   154     C. Der letztere wird zum freien Chromanol der Formel   (IV)    verseift.



   Es lässt sich oxydieren und in das   Tocopheron-    lacton überführen.



   Beispiel 2
20 Teile 2, 3, 5-Trimethylhydrochinon, 20 Teile Linalbol, 2 Teile   Bortrifluoridätherat    und 2 Teile wasserfreier Fluorwasserstoff werden in 200 Teilen wasserfreiem Ather 72 Stunden lang bei   25  C zur    Reaktion gebracht. Aus dem Gemisch wird der Fluorwasserstoff mit Wasser und hernach nicht umgesetztes Hydrochinonderivat mit Alkali und Wasser ausgewaschen. Beim Verdampfen des   Äthers    erhält man ein   Ö1,    welches durch Chromatographie und nachfolgende   Molekulardestilllation    gereinigt wird. Das dabei erhaltene Chromanol wird weiterbehandelt, wie dies in Beispiel   1    beschrieben ist.



  



  Process for the preparation of 2- (3'-hydroxy-3'-methyl-5'-carboxy-pentyl) -3, 5, 6-trimethyl-benzoquinone
The present invention relates to a process for the preparation of 2- (3'-hydroxy-3'-methyl-5'-carS oxy-pentyl) -3, 5, 6-trimethyl-benzoquinone (I), which is used as a starting material for the preparation of the corresponding tocopherone lactone (II) can be used.
EMI1.1

EMI1.2




   These compounds were identified as metabolic products of vitamin E (α-tocopherol) by Simon, Eisengart, Sundheim and Milhorat [cf. J. Biol.



  Chem., (1956), 221, 807] and are believed to be of importance as is the active metabolic form of the vitamin. Tocopheron-lactone was recently discovered by Weichet, Blaha & Kakac [cf. Coll. Czech. Chem. Commun., (1959) 24, 1989].

   The inventive method is characterized in that 2, 3, 5-trimethyl-hydroquinone is condensed with geraniol or linalool under such conditions that the formation of tricyclic products does not occur or occurs only to a reduced extent, and then the resulting
2, 5, 7, 8-tetramethyl-2- (4'-methylpent-3'-enyl) chroman-6-ol of the formula
EMI1.3
 on the olefinic double bond to the chromanol of the formula
EMI2.1
 oxidized and this further oxidized to the benzoquinone of the formula I. Reaction conditions suitable for the first stage are e.g.

   B. the use of condensing agents such as hydrogen fluoride or boron trifluoride etherate, preferably together with condensing agents such as sulfuric acid, formic acid, tin chloride or zinc chloride in an inert solvent at temperatures between room temperature and 120 C, in particular between 25 and 50 C. The resulting cromanol (III is then, ideally under exactly observed oxidation conditions, oxidized to chromanol (IV) and then to hydroxy acid (I). The latter can be converted into tocopherone lactone (II) by known processes. Ozone has proven to be a particularly suitable oxidizing agent for the oxidation mentioned .

   The product obtained on exposure to ozone is worked up under oxidizing conditions, as are known for converting olefini; shear substances in acids. The hydroxyl group of the chromanol (III), which is subject to oxidation under certain conditions, can optionally be converted beforehand into another group such as an ester or ether group, and the compound protected in this way from undesired oxidation by means of ozone or another oxidizing group Agent such as B. a chromic acid mixture, are oxidized.

   Examples of such esters are acetate, propionate or benzoate and examples of breath are methyl, ethyl and benzyl ethers. After the oxidation, the protective group can be removed by known processes (ester by means of hydrolysis, the benzyl group by means of hydrogenolysis, etc.), whereby the tocopherone lactone is formed.



   In the following examples the parts given are weight units.



   example 1
20 parts of 2, 3, 5-trimethylhydroquinone, 20 parts of geraniol and 5 parts of BF3 etherate are heated to 50 ° C. in 200 parts of peroxide-free dioxane for 8 hours. The mixture is then diluted with petroleum ether and the dioxane and unchanged hydroquinone derivative are washed out of it first with alkali and then with water. The oil obtained is chromatographed on aluminum oxide.

   After terpene-like substances have been eluted with benzene, elution with 5% ethanol in benzene gives a light yellow oil. It is distilled in a short-path molecular style flask (120 ° C., 10 microns), with the chromanol (III) in the form of an oil n D 20 = 1.5323 is obtained. 20 parts of this chromanol are acetylated and, without the acetate having been isolated, dissolved in 600 parts of acetic acid at room temperature, after which dry ozone-containing oxygen is blown through the solution.



  After the amount of ozone required to oxidize a double bond has been absorbed, the solution is slowly added to a mixture of 30% hydrogen peroxide and sulfuric acid and then carefully heated. The mixture is now refluxed for 2 hours. After cooling, the mixture is extracted with ether. After evaporation of the solvent from the ether extract, the acetate of chromanol (IV) of melting point 154 C. is obtained. The latter is saponified to give the free chromanol of the formula (IV).



   It can be oxidized and converted into tocopherone lactone.



   Example 2
20 parts of 2, 3, 5-trimethylhydroquinone, 20 parts of linalbol, 2 parts of boron trifluoride ether and 2 parts of anhydrous hydrogen fluoride are reacted in 200 parts of anhydrous ether at 25 ° C. for 72 hours. The hydrogen fluoride is washed out of the mixture with water and then unreacted hydroquinone derivative with alkali and water. When the ether is evaporated, an oil is obtained which is purified by chromatography and subsequent molecular distillation. The chromanol obtained in this way is treated further as described in Example 1.

 

Claims (1)

PATENTANSPRUCH I Verfahren zur Herstellung von 2-(3'-Hydroxy-3'-methyl-5'-carboxy-pentyl)- 3, 5, 6-tnmethyl-benzochinon, dadurch gekennzeichnet, dass 2, 3, 5-Trimethyl-hydro- chinon mit Geraniol oder Linalool unter solchen Bedingungen kondensiert wird, dass die Bildung tri cycischer Produkte höchstens in vermindertem Ausmass eintritt, worauf das so erhaltene 2, 5, 7, 8-Tetramethyl-2- (4'-methyl-pent-3'-enyl)- chroman-6-ol (III) an der olefinischen Doppelbindung zum Chromanol der Formel (IV) oxydiert und anschliessend zum entsprechenden Benzochinon weiter oxydiert wird. PATENT CLAIM I Process for the preparation of 2- (3'-Hydroxy-3'-methyl-5'-carboxy-pentyl) - 3, 5, 6-tnmethyl-benzoquinone, characterized in that 2, 3, 5-trimethyl-hydroquinone is condensed with geraniol or linalool under such conditions that the formation of tricyclic products occurs at most to a reduced extent, whereupon it does so received 2, 5, 7, 8-tetramethyl-2- (4'-methyl-pent-3'-enyl) -chroman-6-ol (III) is oxidized at the olefinic double bond to give the chromanol of the formula (IV) and then to the corresponding Benzoquinone is further oxidized. UNTERANSPRÜCHE I-Verfahren nach Patentanspruch I, dadurch gekennzeichnet, dass die Umsetzung des 2, 3, 5-Tri- methyl-hydrochinons mit dem Geranioll oder Linalool in einem inerten Lösungsmittel in Gegenwart von Fluorwasserstoff oder Bortrifluorid-ätheralt durch- geführt wird. SUBClaims I method according to claim I, characterized in that the reaction of the 2, 3, 5-trimethyl-hydroquinone with the geranioll or linalool is carried out in an inert solvent in the presence of hydrogen fluoride or boron trifluoride ether. 2. Verfahren nach Patentanspruch I, dadurch gekennzeichnet, d'ass die Reaktion bei einer Temperatur zwischen Zimmertemperatur und 120 C, vorzugsweise zwischen 25 und 50 C, durchgeführt wird. 2. The method according to claim I, characterized in that the reaction at a temperature between room temperature and 120 C, preferably between 25 and 50 C, is carried out. 3. Verfahren nach Patentanspruch I, dadurch gekennzeichnet, dass die Hydroxygruppe des Chro- manols (III) vor der Oxydation durch Verestem oder Veräthern geschützt und die schützende Gruppe nach der Oxydation wieder abgespalten wird. 3. The method according to claim I, characterized in that the hydroxyl group of the chromanol (III) is protected from the oxidation by esterification or etherification and the protective group is split off again after the oxidation. 4. Verfahren nach Patentanspruch I und Unteranspruch 3, dadurch gekennzeichnet, dass die Oxydation der olefinischen Doppelbindung mit Ozon vorgenommen wird. 4. The method according to claim I and dependent claim 3, characterized in that the oxidation of the olefinic double bond is carried out with ozone. PATENTANSPRUCH II Verwendung des gemäss Patentanspruch I hergestellten 2- (3'-Hydroxy-3'-methyl-5'-carboxy-pentyl) 3, 5, 6-trimethyl-benzochinons zur Herstellung von Tocopheronlacton der Formel II. PATENT CLAIM II Use of the prepared according to claim I. 2- (3'-Hydroxy-3'-methyl-5'-carboxy-pentyl) 3, 5, 6-trimethyl-benzoquinones for the production of tocopherone lactone of the formula II.
CH367262A 1961-04-12 1962-03-27 Process for the preparation of 2- (3'-hydroxy-3'-methyl-5'-carboxy-pentyl) -3,5,6-trimethyl-benzoquinone CH421072A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1321961A GB949715A (en) 1961-04-12 1961-04-12 Improvements in or relating to chromanols

Publications (1)

Publication Number Publication Date
CH421072A true CH421072A (en) 1966-09-30

Family

ID=10018991

Family Applications (1)

Application Number Title Priority Date Filing Date
CH367262A CH421072A (en) 1961-04-12 1962-03-27 Process for the preparation of 2- (3'-hydroxy-3'-methyl-5'-carboxy-pentyl) -3,5,6-trimethyl-benzoquinone

Country Status (2)

Country Link
CH (1) CH421072A (en)
GB (1) GB949715A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0537954A1 (en) * 1991-10-15 1993-04-21 Takeda Chemical Industries, Ltd. Process of preparing diphenylmethane derivatives
WO1996005191A1 (en) * 1994-08-15 1996-02-22 Loma Linda University Medical Center Natriuretic cyclic compounds

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947473A (en) * 1972-12-22 1976-03-30 Hoffman-La Roche Inc. Antioxidant chroman compounds
US3986980A (en) * 1974-04-29 1976-10-19 Hoffmann-La Roche Inc. Synergistic antioxidant composition comprising ascorbic acid and 6-hydroxy-2,5,7,8-tetramethylchroman-2- carboxylic acid
US4824971A (en) * 1986-01-23 1989-04-25 Hoffman-La Roche Inc. 2-allylchromans
ATE41151T1 (en) * 1986-01-23 1989-03-15 Hoffmann La Roche 3,4-DIHYDRO-2,5,7,8-TETRAMETHYL-2H-1BENZOPYRANE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0537954A1 (en) * 1991-10-15 1993-04-21 Takeda Chemical Industries, Ltd. Process of preparing diphenylmethane derivatives
WO1996005191A1 (en) * 1994-08-15 1996-02-22 Loma Linda University Medical Center Natriuretic cyclic compounds
US6083982A (en) * 1994-08-15 2000-07-04 Loma Linda University Medical Natriuretic compounds
US6150402A (en) * 1994-08-15 2000-11-21 Loma Linda University Medical Center Natriuretic compounds

Also Published As

Publication number Publication date
GB949715A (en) 1964-02-19

Similar Documents

Publication Publication Date Title
WO1994005650A1 (en) Isolation of tocopherol and sterol
DE2743920C2 (en) Process for the preparation of dl-α-tocopherol
DE1923223A1 (en) Derivatives of 1-Aethyl-3,3-dimethyl-cyclo-hexane and process for their preparation
CH421072A (en) Process for the preparation of 2- (3'-hydroxy-3'-methyl-5'-carboxy-pentyl) -3,5,6-trimethyl-benzoquinone
EP0857722B1 (en) Process for the preparation of tocopherylcarboxylic acid esters or tocotrienyl esters by acid catalysed reaction with carboxylic acids
DE2536503A1 (en) 1,1-DICHLORO-4-METHYL-3-HYDROXY- PENTEN-(1)
CH412933A (en) Process for the preparation of 2,5,7,8-tetramethyl-2- (2'-carboxy-ethyl) -chroman-6-ol
AT239213B (en) Process for the preparation of β- [2- (5-substituted) furyl] propionic acid esters
AT215995B (en) Process for the production of new chroman derivatives
DE962074C (en) Process for the preparation of 4- [2 ', 6', 6'-trimethylcyclohexylidene] -2-methylbutene- (2) -als- (1) (iso-C-aldehyde) or 4- [2 ', 6', 6'-trimethylcyclohexen- (2 ') - ylidene] -2-methylbutene- (2) -als- (1) (retrodehydro-C-aldehyde)
DE895900C (en) Process for the production of fatty acid alkali salts or free fatty acids by cleaving esters
Andrews et al. Oxidation of monoethenoid fatty acids and esters: Catalytic oxidation of ethylene glycol dielaidate
DE2653518C3 (en) Process for the production of neutral aldehyde-free methyl benzoate
DE712744C (en) Process for the preparation of vod d, 1-acetyl-ª ‡ -tocopherol
CH255097A (en) Process for the preparation of an aldehyde from B-ionone.
AT242690B (en) Process for the preparation of derivatives of 2,3-dimethoxy-5-methyl-benzohydroquinone- (1,4) and the associated quinones
DE1099520B (en) Process for the production of monoglycerides of fatty acids with 8 to 22 carbon atoms
AT214432B (en) Process for the preparation of mono- and / or disubstitution products of dimethylbenzohydroquinones- (1,4) and the associated quinones
DE2034014C3 (en) Process for the preparation of straight-chain aliphatic carboxylic acids
DE956508C (en) Process for the preparation of dihydrosantonine pellets
DE961165C (en) Process for the preparation of 6- [2 ', 6', 6'-trimethylcyclohexylidene] -4-methylhexadiene- (2, 4) -als- (1) (iso-C-aldehyde), of 6- [2 ', 6 ', 6', - trimethylcyclohexen- (2 ') - ylidene] -4-methyl-hexadiene- (2', 4) -als- (1) (retrodehydro-C-aldehyde) or of 6- [2 ', 6 ', 6'-trimethylcyclohexadien- (1', 3 ') - yl] -4-methyl-hexadien- (2, 4) -as- (1) (ª ‰ -dehydro-C-aldehyde)
DE1518246C (en) Process for the production of sucrose esters of substituted stearic acids
DE2818150B2 (en) Process for the production of terpenoid alcohols or their formic acid esters
CH604714A5 (en) Perfume compsn.
DE1076683B (en) Process for the preparation of the formic acid esters of 1-alkynylcycloalkanols